Envestnet Asset Management Inc Biotechnology

Envestnet Asset Management Inc

$302 Billion
Q4 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
APLS Apellis Pharmaceuticals, Inc.	$1.98B	$891,000 0.0% of portfolio	27,951	Q4 2024 Reduced 82.04%
AGIO Agios Pharmaceuticals, Inc.	$1.5B	$815,000 0.0% of portfolio	24,805	Q4 2024 Added 3.31%
NTLA Intellia Therapeutics, Inc.	$602M	$777,000 0.0% of portfolio	66,654	Q4 2024 Reduced 16.66%
DNLI Denali Therapeutics Inc.	$1.76B	$766,000 0.0% of portfolio	37,622	Q4 2024 Added 34.47%
BEAM Beam Therapeutics Inc.	$1.28B	$755,000 0.0% of portfolio	30,467	Q4 2024 Added 8.15%
TARS Tarsus Pharmaceuticals, Inc.	$1.31B	$671,000 0.0% of portfolio	12,133	Q4 2024 Reduced 15.83%
AVXL Anavex Life Sciences Corp.	$683M	$634,000 0.0% of portfolio	59,066	Q4 2024 Added 54.24%
NUVL Nuvalent, Inc.	$3.01B	$522,000 0.0% of portfolio	6,673	Q4 2024 Reduced 37.08%
RVMD Revolution Medicines, Inc.	$3.21B	$499,000 0.0% of portfolio	11,425	Q4 2024 Added 21.75%
MLTX Moon Lake Immunotherapeutics	$1.42B	$476,000 0.0% of portfolio	8,971	Q4 2024 Reduced 2.11%
RCKT Rocket Pharmaceuticals, Inc.	$543M	$407,000 0.0% of portfolio	32,422	Q4 2024 Added 4.11%
WVE Wave Life Sciences Ltd.	$514M	$399,000 0.0% of portfolio	32,331	Q4 2024 Added 64.9%
SRRK Scholar Rock Holding Corp	$1.59B	$392,000 0.0% of portfolio	9,073	Q4 2024 Reduced 14.52%
EWTX Edgewise Therapeutics, Inc.	$850M	$391,000 0.0% of portfolio	14,678	Q4 2024 Added 32.03%
BBIO Bridge Bio Pharma, Inc.	$4.97B	$354,000 0.0% of portfolio	12,926	Q4 2024 Reduced 18.58%
PTGX Protagonist Therapeutics, Inc	$2.27B	$346,000 0.0% of portfolio	8,981	Q4 2024 Reduced 29.74%
ROIV Roivant Sciences Ltd.	$7.07B	$318,000 0.0% of portfolio	26,921	Q4 2024 New
OLMA Olema Pharmaceuticals, Inc.	$179M	$291,000 0.0% of portfolio	50,062	Q4 2024 Added 0.55%
AKRO Akero Therapeutics, Inc.	$1.75B	$282,000 0.0% of portfolio	10,164	Q4 2024 Reduced 5.08%
VERU Veru Inc.	$41.7M	$264,000 0.0% of portfolio	406,755	Q4 2024 Added 22.98%
INVA Innoviva, Inc.	$1.27B	$257,000 0.0% of portfolio	14,853	Q4 2024 Reduced 15.1%
ETON Eton Pharmaceuticals, Inc.	$363M	$233,000 0.0% of portfolio	17,740	Q4 2024 New
ACLX Arcellx, Inc.	$2.72B	$209,000 0.0% of portfolio	2,747	Q4 2024 Reduced 26.67%
ABSI Absci Corp	$287M	$208,000 0.0% of portfolio	79,549	Q4 2024 Reduced 15.4%
IOVA Iovance Biotherapeutics, Inc.	$486M	$206,000 0.0% of portfolio	27,931	Q4 2024 Reduced 4.92%
MIST Milestone Pharmaceuticals Inc.	$26.7M	$150,000 0.0% of portfolio	63,742	Q4 2024 Reduced 9.7%
LRMR Larimar Therapeutics, Inc.	$82.6M	$135,000 0.0% of portfolio	35,525	Q4 2024 Added 12.25%
MRVI Maravai Lifesciences Holdings, Inc.	$233M	$103,000 0.0% of portfolio	19,016	Q4 2024 Reduced 55.46%
CABA Cabaletta Bio, Inc.	$31.9M	$85,000 0.0% of portfolio	38,904	Q4 2024 Reduced 19.07%
CRBU Caribou Biosciences, Inc.	$45M	$73,000 0.0% of portfolio	46,301	Q4 2024 Added 43.44%
ABCL Ab Cellera Biologics Inc.	$699M	$53,000 0.0% of portfolio	18,428	Q4 2024 Reduced 20.6%
CDXC Chroma Dex Corp.	$420M	$53,000 0.0% of portfolio	10,000	Q3 2023 Reduced 37.52%
ALLO Allogene Therapeutics, Inc.	$204M	$44,000 0.0% of portfolio	21,089	Q4 2024 Added 35.19%
PGEN Precigen, Inc.	$289M	$29,000 0.0% of portfolio	26,343	Q4 2024 Added 28.96%
HRTX Heron Therapeutics, Inc.	$219M	$27,000 0.0% of portfolio	17,748	Q4 2024 Reduced 36.25%
CGEN Compugen LTD	$127M	$17,000 0.0% of portfolio	11,497	Q4 2024 Reduced 40.51%
GBIO Generation Bio Co.	$23M	$14,000 0.0% of portfolio	14,104	Q4 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.